Transfusion Strategies for Acute Upper Gastrointestinal Bleeding
NEJM, 2013 · Single-center randomized controlled trial (n=921)
Clinical question
Does a restrictive transfusion strategy improve outcomes compared with a liberal strategy in acute upper GI bleeding?
What the trial found
Restrictive transfusion significantly improved 45-day survival and reduced rebleeding, particularly in cirrhotic patients.
Current guideline position
AASLD, ACG, and International Consensus guidelines strongly recommend a restrictive RBC transfusion strategy (target Hb 7.0–8.0 g/dL) in acute upper gastrointestinal bleeding.
Clinical interpretation
Firmly established the restrictive transfusion threshold (Hb < 7.0 g/dL) in acute UGIB.
Risk-stratified non-variceal and variceal hemorrhage care: resuscitation, selective airway protection, individualized transfusion, PPI or portal-pressure therapy, endoscopic hemostasis, and escalation to IR/TIPS/surgery when indicated.
Patient-specific RBC transfusion thresholds, current platelet/procedural thresholds, plasma/cryoprecipitate use, and the TRALI vs TACO diagnostic matrix.
The trauma lethal diamond (hypothermia, acidosis, coagulopathy, hypocalcemia), 1:1:1 massive transfusion (PROPPR trial), early TXA (CRASH-2), and TEG/ROTEM algorithms.